Case study

Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program

Switching from one vaccine product to another can have a significant impact on a country’s budget. For Palestine’s rotavirus vaccination program, a switch paid off.

This brief describes an economic analysis conducted by PATH in partnership with the Rostropovich-Vishnevskaya Foundation and the Palestinian Ministry of Health to assess the economic implications of Palestine’s switch from ROTARIX to ROTAVAC.

Authors

Publication year

2020

Type

Case study

Categories

  • Programme management

Diseases

  • Rotavirus

Organisations

  • PATH

Tags

  • Planning, budgeting and financing

PORTFOLIO-LESSONS

This resource appears in the following Hot Topic page:

The resource is included in the following table:

TitleAuthorYearTypeLanguage
The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questionsPATH2022ReportEnglish
The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact AnalysisPATH, Rostropovich-Vishnevskaya Foundation, Palestine Ministry of Health2021ReportRussian
Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization ProgramPATH2020Case studyArabic, English, Russian, French
Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research FindingsDose Per Container Partnership (DPCP), JSI2019Case studyEnglish
The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in ZambiaKirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass2020Journal articleEnglish
A Switch for Sustainability in Ghana's Rotavirus Vaccine ProgramGeorge Armah2020Case studyEnglish
The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands HAPPI2025ReportEnglish
Economic implications of switching to the hexavalent infant vaccine in an immunization program in IndiaPawan Kumar, Kapil Singh, Arindam Ray, Arup Deb Roy, Susmita Chatterjee, Homero Hernandez, Amrita Kumari2026Journal articleEnglish

Added by: Laura Kallen

Added on: 2020-12-17 09:31:04

Hits: 2146